APA (7th ed.) Citation

Tian, M., Cheuk, A. T., Wei, J. S., Abdelmaksoud, A., Chou, H., Milewski, D., . . . Khan, J. (2022). An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma. The Journal of clinical investigation, 132(16), . https://doi.org/10.1172/JCI155621

Chicago Style (17th ed.) Citation

Tian, Meijie, et al. "An Optimized Bicistronic Chimeric Antigen Receptor Against GPC2 or CD276 Overcomes Heterogeneous Expression in Neuroblastoma." The Journal of Clinical Investigation 132, no. 16 (2022). https://doi.org/10.1172/JCI155621.

MLA (9th ed.) Citation

Tian, Meijie, et al. "An Optimized Bicistronic Chimeric Antigen Receptor Against GPC2 or CD276 Overcomes Heterogeneous Expression in Neuroblastoma." The Journal of Clinical Investigation, vol. 132, no. 16, 2022, https://doi.org/10.1172/JCI155621.